scholarly journals A randomized, phase II trial of cetuximab with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer

2015 ◽  
Vol 26 (3) ◽  
pp. 556-561 ◽  
Author(s):  
A. Jimeno ◽  
K. Shirai ◽  
M. Choi ◽  
J. Laskin ◽  
M. Kochenderfer ◽  
...  
Keyword(s):  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Kinase Inhibitor ◽  
Phase Ii Trial ◽  
Squamous Cell Cancer ◽  
Cell Cancer ◽  
Phosphatidylinositol 3 Kinase ◽  
Randomized Phase Ii ◽  
Neck Squamous Cell Cancer

scholarly journals Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer

2017 ◽  
Vol 22 (7) ◽  
pp. 782 ◽  
Author(s):  
Marco Siano ◽  
Francesca Molinari ◽  
Vittoria Martin ◽  
Nicolas Mach ◽  
Martin Früh ◽  
...  
Keyword(s):  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Squamous Cell Cancer ◽  
Phase Ii Study ◽  
Cell Cancer ◽  
Advanced Head ◽  
Multicenter Phase ◽  
Neck Squamous Cell Cancer

scholarly journals A phase II trial of palliative docetaxel plus 5-fluorouracil for squamous-cell cancer of the head and neck

2000 ◽  
Vol 11 (5) ◽  
pp. 535-540 ◽  
Author(s):  
A.D. Colevas ◽  
S. Adak ◽  
P.C. Amrein ◽  
J.J. Barton ◽  
R. Costello ◽  
...  
Keyword(s):  
Head And Neck ◽  
Phase Ii ◽  
Squamous Cell ◽  
Phase Ii Trial ◽  
Squamous Cell Cancer ◽  
Cell Cancer
Sign in / Sign up

Export Citation Format

Share Document